July « 2021 « Science and Enterprise

Save On Energy With These Tips

By Alan, on July 23rd, 2021%

There are plenty of ways that you can ensure that the energy industry is getting what’s needed from you and no more. . . . → Read More: Save On Energy With These Tips

Covid-19 Delta Variant Testing Reference Released

By Alan, on July 22nd, 2021%

A company designing synthetic DNA and RNA says reference materials are available for tests that detect the quickly spreading Covid-19 delta variant. . . . → Read More: Covid-19 Delta Variant Testing Reference Released

Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

By Alan, on July 21st, 2021%

A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

ALS Drug Maker Gains $135M in New Funds

By Alan, on July 20th, 2021%

A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds

Pooled Saliva Tests Detect Covid-19 in Schools

By Alan, on July 19th, 2021%

Preparing classrooms for students return

Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests. . . . → Read More: Pooled Saliva Tests Detect Covid-19 in Schools

Infographic – 2021 Black Start-Up Funding Rises

By Alan, on July 17th, 2021%

Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low. . . . → Read More: Infographic – 2021 Black Start-Up Funding Rises

Trial to Test Antibody Drug for Alzheimer’s Prevention

By Alan, on July 16th, 2021%

Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals. . . . → Read More: Trial to Test Antibody Drug for Alzheimer’s Prevention

Immune Cell Cancer Biotech Gains $172M in New Funds

By Alan, on July 15th, 2021%

A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds

$60M Challenge Seeks RNA Bio-Production Network

By Alan, on July 14th, 2021%

A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network

Precision Gene-Editing Biotech Gains $200M in New Funds

By Alan, on July 13th, 2021%

A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise